Thoratec Corporation is engaged in the research, development, manufacturing and marketing of medical devices for circulatory support, vascular graft, blood coagulation and skin incision applications. The Thoratec® Ventricular Device (VAD) System is the only ventricular assist device that is approved for use as both a bridge-to-transplant and for recovery from open-heart surgery. More than 3,482 devices have been used in the treatment of more than 2,306 patients worldwide. The company is also a leader in implantable left ventricular assist systems (LVAS). Its air-driven and electric HeartMate® heart assist devices, which have been implanted in more than 3,600 patients worldwide, are implanted alongside the natural heart and take over the pumping function of the left ventricle for patients whose hearts are too damaged or diseased to produce adequate blood flow.
VCR Price at posting:
0.0¢ Sentiment: Buy Disclosure: Not Held
